Promethos Capital’s Bristol-Myers Squibb BMY Stock Holding History

Promethos Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.39M	Sell	105,346 -6,410	-6%	-$374K	1.72%	23
2025 Q4	$6.03M	Sell	111,756 -6,419	-5%	-$309K	1.64%	24
2025 Q3	$5.33M	Buy	118,175 +36,596	+45%	+$1.71M	1.43%	32
2025 Q2	$3.78M	Hold	81,579	–	–	1.27%	31
2025 Q1	$4.98M	Sell	81,579 -2,130	-3%	-$124K	1.83%	19
2024 Q4	$4.73M	Buy	83,709 +82,515	+6,911%	+$4.61M	1.67%	24
2024 Q3	$61.8K	Hold	1,194	–	–	0.02%	52
2024 Q2	$49.6K	Hold	1,194	–	–	0.02%	50
2024 Q1	$64.8K	Hold	1,194	–	–	0.04%	47
2023 Q4	$61.3K	Buy	+1,194	New	+$62.7K	0.04%	44

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Promethos Capital's BMY Position: Q1 2026 in Review

Promethos Capital reduced its Bristol-Myers Squibb (BMY) stake by 5.7% in Q1 2026, selling an estimated $374K and leaving 105,346 shares worth $6.39M. The position accounts for 1.72% of the portfolio, ranked #23.

Promethos Capital first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Promethos Capital held 105,346 shares of Bristol-Myers Squibb worth $6.39M as of Q1 2026.
Promethos Capital sold 6,410 Bristol-Myers Squibb shares in Q1 2026, an estimated $374K.
Bristol-Myers Squibb made up 1.72% of Promethos Capital's portfolio in Q1 2026, its #23 holding.
Promethos Capital first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Promethos Capital's 13F filing for Q1 2026, filed 13 May 2026.